-
￡50 blood test could predict prostate cancer drug response
pharmatimes
May 05, 2017
Researchers have developed a blood test that could better tailor the treatment of patients with prostate cancer.
-
AstraZeneca’s Imfinzi receives FDA-accelerated approval for urothelial cancer
pharmaceutical-technology
May 04, 2017
The US Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Imfinzi (durvalumab) ...
-
Study discovers origin of cancer metastases and why they reoccur
pharmafile
May 04, 2017
A team of scientists from The Scripps Research Institute (TSRI) have discovered the secrets of where metastases...
-
Aeterna Zentaris’ endometrial cancer drug fails in Phase III
pharmatimes
May 04, 2017
A late stage clinical study of Aeterna Zentaris’ Zoptrex in women with locally advanced, recurrent or metastatic...
-
AZ’ Imfinzi gets accelerated nod for bladder cancer
pharmatimes
May 04, 2017
AstraZeneca has secured accelerated approval in the US for its immunotherapy Imfinzi as a treatment for certain patients with advanced bladder cancer.
-
England's Cancer Drugs Fund 'failed to deliver meaningful value to patients and society'
worldpharmanews
May 03, 2017
Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily from toxic side effects of the dru
-
Cancer Drugs Fund poor value for money, study finds
pharmatimes
May 02, 2017
England’s Cancer Drugs Fund is poor value for money and may be exposing patients to unnecessary harm, concludes ...
-
England's Cancer Drugs Fund 'failed to deliver meaningful value to patients and society'
worldpharmanews
May 02, 2017
Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily from toxic side effects of the dru
-
Studying unstable chromosomes can help predict cancer relapse, says Cancer Research UK
pharmaceutical-technology
April 28, 2017
Cancer Research UK-funded TRACERx lung cancer study has claimed that unstable chromosomes within lung tumours ...
-
Blood test able to detect cancer a year in advance
pharmafile
April 28, 2017
A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients...
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
